These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26872310)

  • 1. Liver X receptor as a drug target for the treatment of breast cancer.
    Wu Y; Yu DD; Yan DL; Hu Y; Chen D; Liu Y; Zhang HD; Yu SR; Cao HX; Feng JF
    Anticancer Drugs; 2016 Jun; 27(5):373-82. PubMed ID: 26872310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol and breast cancer pathophysiology.
    Nelson ER; Chang CY; McDonnell DP
    Trends Endocrinol Metab; 2014 Dec; 25(12):649-55. PubMed ID: 25458418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism.
    Nguyen-Vu T; Vedin LL; Liu K; Jonsson P; Lin JZ; Candelaria NR; Candelaria LP; Addanki S; Williams C; Gustafsson JÅ; Steffensen KR; Lin CY
    Breast Cancer Res; 2013 Jun; 15(3):R51. PubMed ID: 23809258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging roles of liver X receptors and their ligands in cancer.
    Lin CY; Vedin LL; Steffensen KR
    Expert Opin Ther Targets; 2016; 20(1):61-71. PubMed ID: 26788589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-adopting classical nuclear receptors by cholesterol metabolites.
    Umetani M
    J Steroid Biochem Mol Biol; 2016 Mar; 157():20-6. PubMed ID: 26563834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen deprivation and inhibition of breast cancer growth in vivo through activation of the orphan nuclear receptor liver X receptor.
    Gong H; Guo P; Zhai Y; Zhou J; Uppal H; Jarzynka MJ; Song WC; Cheng SY; Xie W
    Mol Endocrinol; 2007 Aug; 21(8):1781-90. PubMed ID: 17536009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice.
    Chen W; Chen G; Head DL; Mangelsdorf DJ; Russell DW
    Cell Metab; 2007 Jan; 5(1):73-9. PubMed ID: 17189208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oxysterol receptor LXR inhibits proliferation of human breast cancer cells.
    Vedin LL; Lewandowski SA; Parini P; Gustafsson JA; Steffensen KR
    Carcinogenesis; 2009 Apr; 30(4):575-9. PubMed ID: 19168586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers.
    Roshan-Moniri M; Hsing M; Butler MS; Cherkasov A; Rennie PS
    Cancer Treat Rev; 2014 Dec; 40(10):1137-52. PubMed ID: 25455729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.
    Oosterveer MH; Grefhorst A; Groen AK; Kuipers F
    Prog Lipid Res; 2010 Oct; 49(4):343-52. PubMed ID: 20363253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice.
    Han SI; Komatsu Y; Murayama A; Steffensen KR; Nakagawa Y; Nakajima Y; Suzuki M; Oie S; Parini P; Vedin LL; Kishimoto H; Shimano H; Gustafsson JÅ; Yanagisawa J
    Hepatology; 2014 May; 59(5):1791-802. PubMed ID: 24277692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP3A induction by liver x receptor ligands in primary cultured rat and mouse hepatocytes is mediated by the pregnane X receptor.
    Shenoy SD; Spencer TA; Mercer-Haines NA; Alipour M; Gargano MD; Runge-Morris M; Kocarek TA
    Drug Metab Dispos; 2004 Jan; 32(1):66-71. PubMed ID: 14709622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage apolipoprotein E and proliferation of MCF-7 breast cancer cells: role of LXR.
    El Roz A; Bard JM; Valin S; Huvelin JM; Nazih H
    Anticancer Res; 2013 Sep; 33(9):3783-9. PubMed ID: 24023310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LXR-dependent and -independent effects of oxysterols on immunity and tumor growth.
    Traversari C; Sozzani S; Steffensen KR; Russo V
    Eur J Immunol; 2014 Jul; 44(7):1896-903. PubMed ID: 24777958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of liver X receptor signaling as novel therapy for prostate cancer.
    Chuu CP; Kokontis JM; Hiipakka RA; Liao S
    J Biomed Sci; 2007 Sep; 14(5):543-53. PubMed ID: 17372849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxysterol receptors and their therapeutic applications in cancer conditions.
    De Boussac H; Alioui A; Viennois E; Dufour J; Trousson A; Vega A; Guy L; Volle DH; Lobaccaro JM; Baron S
    Expert Opin Ther Targets; 2013 Sep; 17(9):1029-38. PubMed ID: 23875732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer and (25R)-26-hydroxycholesterol.
    Javitt NB
    Steroids; 2015 Dec; 104():61-4. PubMed ID: 26299212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells.
    Premaratne A; Ho C; Basu S; Khan AF; Bawa-Khalfe T; Lin CY
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression and treatment of HER2-positive breast cancer.
    Davoli A; Hocevar BA; Brown TL
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):611-23. PubMed ID: 20087739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.